AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,201,387 | -38.0% | 284,689 | -54.5% | 0.00% | -33.3% |
| Q2 2023 | $1,938,984 | -26.9% | 625,479 | -67.2% | 0.00% | -25.0% |
| Q1 2023 | $2,653,401 | -15.8% | 1,908,922 | +20.6% | 0.00% | -20.0% |
| Q4 2022 | $3,150,904 | +93.2% | 1,583,369 | +96.0% | 0.01% | +66.7% |
| Q3 2022 | $1,631,000 | +57.1% | 807,662 | +147.4% | 0.00% | +50.0% |
| Q2 2022 | $1,038,000 | -23.5% | 326,435 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,356,000 | -36.8% | 325,249 | -27.4% | 0.00% | 0.0% |
| Q4 2021 | $2,144,000 | – | 447,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |